Purpose
to use optogenetics in monoclonal antibody manufacturing to reduce the cost of goods and make them affordable and accessible to vulnerable populations in lower- and middle-income countries
Grantee
Division
Global Health
Date
JULY 2024
Region served
GLOBAL
Committed amount
$3,179,736
Grant topic
Discovery and Translational Sciences,
Research and Learning Opportunities,
Vaccine Development
Duration (months)
21
Grantee location
Emeryville, California, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.